Bamlanivimab FDA EUA for COVID

Bamlanivimab FDA EUA for COVID

More lectures on drbeen.com

Buy me a coffee :-)
https://www.buymeacoffee.com/DrMobeenSyed

Looking to support my educational work? Donate here:
https://paypal.me/mobeensyed?locale.x=en_US

Bamlanivimab is a recombinant antibody by Lilly.
Bamlanivimab is approved for non-hospitalized, non oxygen requiring, non ventilated patients of mild to moderate COVID-19 that are deemed high risk of severe disease.

Criteria for high risk patients
https://www.covid19treatmentguidelines.nih.gov/statement-on-bamlanivimab-eua
DrBeen’s discussion of how monoclonal antibodies are made?
https://youtu.be/Y-qNdFMRiis

DrBeen’s explanation of the recombinant technology
https://youtu.be/Y-qNdFMRiis?t=2339

What are recombinant monoclonal antibodies?
Complete Guide to Recombinant Antibodies | Benefits & Uses

Bamlanivimab mechanism of action
Lilly's neutralizing antibody bamlanivimab (LY-CoV555) receives FDA emergency use authorization for the treatment of recently diagnosed COVID-19 | Eli Lilly and Company

FDA EUA granted An EUA for Bamlanivimab—A Monoclonal Antibody for COVID-19 | Infectious Diseases | JAMA | JAMA Network
Bamlanivimab clinical trial
Bamlanivimab (LY-Cov555) for the Treatment of COVID-19, USA

#drbeen #koolbeens #COVID

Видео Bamlanivimab FDA EUA for COVID канала Drbeen Medical Lectures